133 related articles for article (PubMed ID: 1814611)
1. Studies on nilvadipine. I. Synthesis and structure-activity relationships of 1,4-dihydropyridines containing novel substituents at the 2-position.
Satoh Y; Ichihashi M; Okumura K
Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3189-201. PubMed ID: 1814611
[TBL] [Abstract][Full Text] [Related]
2. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.
Liang JC; Yeh JL; Wang CS; Liou SF; Tsai CH; Chen IJ
Bioorg Med Chem; 2002 Mar; 10(3):719-30. PubMed ID: 11814861
[TBL] [Abstract][Full Text] [Related]
3. Studies on nilvadipine. IV. Synthesis of deuteriated and optically active isopropyl 2-cyano-3-methoxycarbonyl-4-(3-nitrophenyl)-6-methyl-1,4- dihydropyridine-5-carboxylate (nilvadipine).
Satoh Y; Okumura K; Shiokawa Y
Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):950-2. PubMed ID: 8020131
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a 4-(disubstituted phenyl) ring and an aminoalkyl ester group: highly potent and long-lasting calcium antagonists.
Kanno H; Yamaguchi H; Okamiya Y; Sunakawa K; Takeshita T; Naruchi T
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2049-54. PubMed ID: 1423758
[TBL] [Abstract][Full Text] [Related]
5. Novel 2-amino-1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having N,N-dialkylaminoalkoxycarbonyl groups at 3- and/or 5-position.
Kobayashi T; Inoue T; Nishino S; Fujihara Y; Oizumi K; Kimura T
Chem Pharm Bull (Tokyo); 1995 May; 43(5):797-817. PubMed ID: 7553967
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antihypertensive activities of new 1,4-dihydropyridine containing nitroimidazolyl substituent with a nitrooxy group at the 3-ester position.
Shafiee A; Rastkary N; Jorjani M; Shafaghi B
Arch Pharm (Weinheim); 2002 Mar; 335(2-3):69-76. PubMed ID: 12043457
[TBL] [Abstract][Full Text] [Related]
7. Novel 2-amino-1,4-dihydropyridine calcium antagonists. I. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having nitroxy-alkoxycarbonyl groups at 3- and/or 5-position.
Kobayashi T; Inoue T; Kita Z; Yoshiya H; Nishino S; Oizumi K; Kimura T
Chem Pharm Bull (Tokyo); 1995 May; 43(5):788-96. PubMed ID: 7553966
[TBL] [Abstract][Full Text] [Related]
8. Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-activity relationships for a series of 2-[(heterocyclylmethoxy)methyl] derivatives.
Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
J Med Chem; 1989 Oct; 32(10):2381-8. PubMed ID: 2795609
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of halogen-substituted 1,5-benzothiazepine derivatives and their vasodilating and hypotensive activities.
Inoue H; Konda M; Hashiyama T; Otsuka H; Takahashi K; Gaino M; Date T; Aoe K; Takeda M; Murata S
J Med Chem; 1991 Feb; 34(2):675-87. PubMed ID: 1995892
[TBL] [Abstract][Full Text] [Related]
10. Novel 1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive activity of 3-[4-(substituted amino)phenylalkyl]ester derivatives.
Ashimori A; Ono T; Inoue Y; Morimoto S; Eda M; Uchida T; Ohtaki Y; Fujino Y; Kido H; Ogura Y
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):91-9. PubMed ID: 2049813
[TBL] [Abstract][Full Text] [Related]
11. Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.
Tamazawa K; Arima H; Kojima T; Isomura Y; Okada M; Fujita S; Furuya T; Takenaka T; Inagaki O; Terai M
J Med Chem; 1986 Dec; 29(12):2504-11. PubMed ID: 3023614
[TBL] [Abstract][Full Text] [Related]
12. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
13. Dihydropyrimidine calcium channel blockers. 2. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.
Atwal KS; Rovnyak GC; Kimball SD; Floyd DM; Moreland S; Swanson BN; Gougoutas JZ; Schwartz J; Smillie KM; Malley MF
J Med Chem; 1990 Sep; 33(9):2629-35. PubMed ID: 2391701
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
Kanda A; Haruno A; Miyake H; Nagasaka M
J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 1,4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) and its crystal structure.
Sakoda R; Kamikawaji Y; Seto K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2362-9. PubMed ID: 1446356
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and smooth muscle calcium channel effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrone moiety in the 4-aryl substituent.
Anana RD; Ng H; Howlett SE; Knaus EE
Arch Pharm (Weinheim); 1997 Mar; 330(3):53-8. PubMed ID: 9167447
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist.
Honerjäger P; Seibel K
J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S15-21. PubMed ID: 1283184
[TBL] [Abstract][Full Text] [Related]
18. Long-acting dihydropyridine calcium antagonists. 4. Synthesis and structure-activity relationships for a series of basic and nonbasic derivatives of 2-[(2-aminoethoxy)methyl]-1,4-dihydropyridine calcium antagonists.
Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
J Med Chem; 1990 Feb; 33(2):585-91. PubMed ID: 2153819
[TBL] [Abstract][Full Text] [Related]
19. Nilvadipine: profile of a new calcium antagonist. An overview.
Rosenthal J
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
[TBL] [Abstract][Full Text] [Related]
20. Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents.
Arrowsmith JE; Campbell SF; Cross PE; Stubbs JK; Burges RA; Gardiner DG; Blackburn KJ
J Med Chem; 1986 Sep; 29(9):1696-702. PubMed ID: 2943898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
